Company profile

Triosyn company profile

Triosyn has developed a novel technology to kill disease-causing microorganisms and to treat microbial infections. Its core technology, Triosyn(R) resin, is an iodinated polymer that interacts with and kills all microorganisms on contact, and due to a proprietary demand-release delivery mechanism provides enhanced safety to humans and the environment. The basic formulation of Triosyn(R) has been registered with the EPA and further registration of Triosyn(R) applications are in process.

Business identity

Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
1992-01-01

Headquarters

Headquarters
United States, Vermont, Williston
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$4M
Last funding
Series A / $4M / 2003-06-02
Last equity funding
Series A / $4M
Investors
4
Lead investors
1

Founders and investors

Lead investors

CDP Capital Technology Ventures

Investors

BDC Venture CapitalCDP Capital Technology VenturesInnovatech Grand MontrealSL Ventures

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.